Well funded from the early days after founding the firm by a range of sources to continue their work, Lauren Sciences is structured around addressing the medical challenge in treatment of central nervous system (CNS) diseases that most therapeutic agents, including biologicals, with potential to treat or cure brain diseases, do not cross blood brain barrier (BBB). V-Smart® Platform, breakthrough innovation, winning trifecta for brain delivery, enables non-invasive, triple-targeted CNS delivery of non-BBB penetrant therapeutic agents (nucleic acids, antibodies, biologics, small molecules, etc.). V-Smart® Pipeline includes V-Smart® Nanomedicines in development for CNS indications (ALS, PD, AD, Neuro-HIV, GBM, Chronic Pain, etc.). V-Smart® Nanomedicines for Pharma are in development with pharmaceutical companies proprietary therapeutic agents under confidentiality. V-Smart® Nanomedicines will significantly improve patients lives, as they enable patients to benefit from therapeutic agents whose use is currently unavailable due to BBB, PK, bioavailability or toxicity, long term invasive treatment, or where oral administration is preferable.
